Quarterly report [Sections 13 or 15(d)]

EQUITY - Schedule of Equity Instruments Other than Options (Details)

v3.26.1
EQUITY - Schedule of Equity Instruments Other than Options (Details)
 6 Months Ended
Jun. 30, 2026
$ / shares
shares
Derivative Liabilities Warrants  
Warrants  
Balance at beginning of period (in shares) 21,400,000
Balance at end of period (in shares) 21,400,000
Warrants (derivative liabilities and equity)  
Warrants  
Balance at beginning of period (in shares) 79,394,087
Granted (in shares) 100,000
Balance at end of period (in shares) 79,494,087
Exercisable (in shares) 78,124,087
Weighted - Average Exercise Price  
Balance at beginning of period (in dollars per share) | $ / shares $ 0.95
Granted (in dollars per share) | $ / shares 0.48
Balance at end of period (in dollars per share) | $ / shares 0.95
Exercisable (in dollars per share) | $ / shares $ 0.96
Warrants (derivative liabilities and equity) | Non-Derivative (Equity) Warrants  
Warrants  
Balance at beginning of period (in shares) 57,994,087
Granted (in shares) 100,000
Balance at end of period (in shares) 58,094,087
Exercisable (in shares) 56,724,087
Warrants (derivative liabilities and equity) | Derivative Liabilities Warrants  
Warrants  
Balance at beginning of period (in shares) 21,400,000
Granted (in shares) 0
Balance at end of period (in shares) 21,400,000
Exercisable (in shares) 21,400,000